abstract |
It is intended to provide target-directing drug delivery system (DDS) nanoparticles which accumulate in a target tissue such as an inflammation site in an inflammatory disease and thus are usable as a DDS for therapeutic or diagnostic use aiming at topically supplying a drug or a gene to the affected part. A medicinal composition for treating or diagnosing an inflammatory disease containing sugar chain-modified liposomes in which a sugar chain is bonded to liposome membrane. |